DPCD
gene geneOn this page
Also known as DKFZP566F084RP11-529I10.4
Summary
DPCD (deleted in primary ciliary dyskinesia homolog (mouse), HGNC:24542) is a protein-coding gene on chromosome 10q24.32, encoding Protein DPCD (Q9BVM2). May play a role in the formation or function of ciliated cells.
This gene in mouse encodes a protein that may be involved in the generation and maintenance of ciliated cells. In mouse, expression of this gene increases during ciliated cell differentiation, and disruption of this gene has been linked to primary ciliary dyskinesia.
Source: NCBI Gene 25911 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 46 total
- MANE Select transcript:
NM_015448
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24542 |
| Approved symbol | DPCD |
| Name | deleted in primary ciliary dyskinesia homolog (mouse) |
| Location | 10q24.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP566F084, RP11-529I10.4 |
| Ensembl gene | ENSG00000166171 |
| Ensembl biotype | protein_coding |
| OMIM | 616467 |
| Entrez | 25911 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 14 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000370147, ENST00000370151, ENST00000434727, ENST00000470165, ENST00000475443, ENST00000626968, ENST00000897436, ENST00000897437, ENST00000897438, ENST00000897439, ENST00000897440, ENST00000927874, ENST00000927875, ENST00000927876, ENST00000927877, ENST00000927878
RefSeq mRNA: 5 — MANE Select: NM_015448
NM_001329742, NM_001329743, NM_001329744, NM_001329745, NM_015448
CCDS: CCDS7514, CCDS86141
Canonical transcript exons
ENST00000370151 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001100436 | 101600738 | 101600862 |
| ENSE00001100439 | 101608835 | 101608937 |
| ENSE00001859286 | 101588321 | 101588400 |
| ENSE00001953044 | 101609367 | 101609662 |
| ENSE00003496444 | 101601203 | 101601336 |
| ENSE00003661578 | 101594658 | 101594738 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 98.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.3460 / max 199.4382, expressed in 1708 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106670 | 11.3460 | 1708 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.28 | gold quality |
| right testis | UBERON:0004534 | 98.16 | gold quality |
| sperm | CL:0000019 | 97.59 | gold quality |
| right uterine tube | UBERON:0001302 | 97.51 | gold quality |
| bronchial epithelial cell | CL:0002328 | 97.06 | gold quality |
| testis | UBERON:0000473 | 96.85 | gold quality |
| bronchus | UBERON:0002185 | 96.31 | gold quality |
| pancreatic ductal cell | CL:0002079 | 95.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.09 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.09 | gold quality |
| pituitary gland | UBERON:0000007 | 94.83 | gold quality |
| adult organism | UBERON:0007023 | 93.30 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.20 | gold quality |
| islet of Langerhans | UBERON:0000006 | 93.13 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.96 | gold quality |
| hypothalamus | UBERON:0001898 | 92.94 | gold quality |
| amygdala | UBERON:0001876 | 92.87 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 92.53 | silver quality |
| caudate nucleus | UBERON:0001873 | 92.18 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.94 | gold quality |
| tibialis anterior | UBERON:0001385 | 91.89 | silver quality |
| putamen | UBERON:0001874 | 91.75 | gold quality |
| prefrontal cortex | UBERON:0000451 | 91.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 91.53 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 91.06 | gold quality |
| apex of heart | UBERON:0002098 | 90.96 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.50 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.43 | gold quality |
| heart left ventricle | UBERON:0002084 | 90.21 | gold quality |
| neocortex | UBERON:0001950 | 90.07 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-1 | yes | 26.41 |
| E-CURD-114 | yes | 11.82 |
| E-MTAB-6075 | no | 239.63 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- The mouse homolog of this gene (named Dpcd, for Deleted in a mouse model of Primary Ciliary Dyskinesia) appears to be responsible for an inner arm defect in cilia. (PMID:14630615)
- a novel candidate gene for primary ciliary dyskinesia (PMID:14630615)
- Deciphering cellular and molecular determinants of human DPCD protein in complex with RUVBL1/RUVBL2 AAA-ATPases. (PMID:35901867)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dpcd | ENSDARG00000060501 |
| mus_musculus | Dpcd | ENSMUSG00000041035 |
| rattus_norvegicus | Dpcd | ENSRNOG00000017241 |
| drosophila_melanogaster | CG13901 | FBGN0035164 |
Protein
Protein identifiers
Protein DPCD — Q9BVM2 (reviewed: Q9BVM2)
All UniProt accessions (3): Q9BVM2, Q5JQQ2, Q5JQQ4
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in the formation or function of ciliated cells.
Tissue specificity. Highly expressed in the testis. Weakly expressed in pancreas, skeletal muscle and heart. Expression increases during ciliated cell differentiation.
Similarity. Belongs to the DPCD family.
RefSeq proteins (5): NP_001316671, NP_001316672, NP_001316673, NP_001316674, NP_056263* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026224 | DPCD | Family |
Pfam: PF14913
UniProt features (4 total): sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BVM2-F1 | 90.21 | 0.79 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 136 (showing top):
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, MENSE_HYPOXIA_UP, GOBP_MALE_GAMETE_GENERATION, GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT, CAGCTG_AP4_Q5, GOBP_FOREBRAIN_DEVELOPMENT, GOBP_SPECIFICATION_OF_SYMMETRY, IRF7_01, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_HEAD_DEVELOPMENT, GOBP_LATERAL_VENTRICLE_DEVELOPMENT, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_TELENCEPHALON_DEVELOPMENT
GO Biological Process (9): epithelial cilium movement involved in extracellular fluid movement (GO:0003351), spermatogenesis (GO:0007283), determination of left/right symmetry (GO:0007368), lateral ventricle development (GO:0021670), third ventricle development (GO:0021678), flagellated sperm motility (GO:0030317), establishment of localization in cell (GO:0051649), ventricular system development (GO:0021591), left/right pattern formation (GO:0060972)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): extracellular region (GO:0005576), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ventricular system development | 2 |
| anatomical structure development | 2 |
| cilium movement | 1 |
| extracellular transport | 1 |
| microtubule-based transport | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| determination of bilateral symmetry | 1 |
| left/right pattern formation | 1 |
| telencephalon development | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| establishment of localization | 1 |
| cellular localization | 1 |
| brain development | 1 |
| system development | 1 |
| regionalization | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
420 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DPCD | DNAAF10 | Q96MX6 | 660 |
| DPCD | STK36 | Q9NRP7 | 610 |
| DPCD | AK7 | Q96M32 | 568 |
| DPCD | RTTN | Q86VV8 | 491 |
| DPCD | SPAG6 | O75602 | 484 |
| DPCD | KIF27 | Q86VH2 | 479 |
| DPCD | PKD1L1 | Q8TDX9 | 461 |
| DPCD | POLL | Q9UGP5 | 447 |
| DPCD | DRICH1 | Q6PGQ1 | 433 |
| DPCD | DCAF8L1 | A6NGE4 | 430 |
| DPCD | AK8 | Q96MA6 | 416 |
| DPCD | DCAF8L2 | P0C7V8 | 399 |
| DPCD | DYNC2I2 | Q96EX3 | 388 |
| DPCD | TTLL1 | O95922 | 380 |
| DPCD | MSGN1 | A6NI15 | 379 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LSM3 | LSM1 | psi-mi:“MI:0914”(association) | 0.950 |
| RUVBL2 | DPCD | psi-mi:“MI:0915”(physical association) | 0.940 |
| DPCD | RUVBL2 | psi-mi:“MI:0915”(physical association) | 0.940 |
| RUVBL1 | ZNHIT1 | psi-mi:“MI:0914”(association) | 0.860 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| RUVBL2 | POLR3A | psi-mi:“MI:0914”(association) | 0.640 |
| RUVBL1 | POLR3A | psi-mi:“MI:0914”(association) | 0.640 |
| KSR2 | POLR3A | psi-mi:“MI:0914”(association) | 0.530 |
| RABGGTA | YKT6 | psi-mi:“MI:0914”(association) | 0.530 |
| MYBPHL | DPCD | psi-mi:“MI:0915”(physical association) | 0.400 |
| DPCD | CDC37 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Ruvbl1 | AAR2 | psi-mi:“MI:0914”(association) | 0.350 |
| Ruvbl2 | TTI2 | psi-mi:“MI:0914”(association) | 0.350 |
| Lin7c | AMOTL2 | psi-mi:“MI:0914”(association) | 0.350 |
| RAB18 | ASDURF | psi-mi:“MI:0914”(association) | 0.350 |
| RUVBL2 | ASDURF | psi-mi:“MI:0914”(association) | 0.350 |
| RUVBL1 | ASDURF | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (54): DPCD (Two-hybrid), DPCD (Two-hybrid), DPCD (Proximity Label-MS), DPCD (Proximity Label-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS), DPCD (Affinity Capture-MS)
ESM2 similar proteins: A0A4X1TB62, A2AGL3, A8YXY3, D3ZV31, E9PZQ0, F1LMY4, O60613, O75817, P0CL18, P11716, P16960, P21817, P41214, P46718, P47224, P47816, P50747, P55884, Q08326, Q0II25, Q0IIH8, Q0PNE2, Q16342, Q1JQA1, Q24K21, Q3UX43, Q4G061, Q4R528, Q58CR3, Q5PPG7, Q5R7U7, Q5RA63, Q6AYM4, Q6NYU2, Q80YV4, Q8BKW4, Q8BPA8, Q8CBY8, Q8JZQ9, Q91W86
Diamond homologs: A4IHF8, A5D8N2, Q0P448, Q24K21, Q6AYM4, Q8BPA8, Q9BVM2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 38 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein stabilization | 7 | 13.4× | 2e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
46 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2754 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:101582761:A:AC | donor_gain | 1.0000 |
| 10:101582762:C:CC | donor_gain | 1.0000 |
| 10:101582762:CTGT:C | donor_gain | 1.0000 |
| 10:101582789:C:A | donor_gain | 1.0000 |
| 10:101582803:T:A | donor_gain | 1.0000 |
| 10:101582891:CCT:C | acceptor_loss | 1.0000 |
| 10:101582892:C:G | acceptor_loss | 1.0000 |
| 10:101582893:T:G | acceptor_loss | 1.0000 |
| 10:101583522:T:C | donor_gain | 1.0000 |
| 10:101583546:C:A | donor_gain | 1.0000 |
| 10:101583586:A:AC | donor_gain | 1.0000 |
| 10:101583587:C:CC | donor_gain | 1.0000 |
| 10:101584920:C:CC | acceptor_gain | 1.0000 |
| 10:101584921:T:C | acceptor_gain | 1.0000 |
| 10:101584921:T:TC | acceptor_gain | 1.0000 |
| 10:101585864:A:AC | donor_gain | 1.0000 |
| 10:101585865:C:CC | donor_gain | 1.0000 |
| 10:101586153:CACT:C | acceptor_gain | 1.0000 |
| 10:101600736:A:AG | acceptor_gain | 1.0000 |
| 10:101600737:G:GG | acceptor_gain | 1.0000 |
| 10:101600849:A:T | donor_gain | 1.0000 |
| 10:101601332:AAGAA:A | donor_gain | 1.0000 |
| 10:101601333:AGAA:A | donor_gain | 1.0000 |
| 10:101601334:GAA:G | donor_gain | 1.0000 |
| 10:101601334:GAAG:G | donor_gain | 1.0000 |
| 10:101601335:AA:A | donor_gain | 1.0000 |
| 10:101601335:AAGTG:A | donor_loss | 1.0000 |
| 10:101601336:AG:A | donor_loss | 1.0000 |
| 10:101601337:G:GG | donor_gain | 1.0000 |
| 10:101601337:GTG:G | donor_loss | 1.0000 |
AlphaMissense
1338 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:101600782:T:A | W64R | 0.997 |
| 10:101600782:T:C | W64R | 0.997 |
| 10:101601242:T:A | W104R | 0.997 |
| 10:101601242:T:C | W104R | 0.997 |
| 10:101601246:G:C | R105P | 0.996 |
| 10:101608927:T:C | L166P | 0.996 |
| 10:101600741:G:C | R50T | 0.995 |
| 10:101600742:A:C | R50S | 0.995 |
| 10:101600742:A:T | R50S | 0.995 |
| 10:101601318:T:A | V129D | 0.995 |
| 10:101600750:G:C | R53P | 0.994 |
| 10:101600784:G:C | W64C | 0.994 |
| 10:101600784:G:T | W64C | 0.994 |
| 10:101594702:G:C | A37P | 0.992 |
| 10:101594670:T:A | V26D | 0.991 |
| 10:101594675:T:G | Y28D | 0.989 |
| 10:101600741:G:T | R50I | 0.989 |
| 10:101601252:G:C | R107P | 0.989 |
| 10:101601278:T:G | Y116D | 0.989 |
| 10:101588352:T:A | W6R | 0.988 |
| 10:101588352:T:C | W6R | 0.988 |
| 10:101609367:T:G | Y170D | 0.988 |
| 10:101601249:T:A | I106N | 0.987 |
| 10:101608933:T:A | I168N | 0.987 |
| 10:101601258:T:C | L109P | 0.986 |
| 10:101608836:T:G | Y136D | 0.986 |
| 10:101609375:G:C | K172N | 0.986 |
| 10:101609375:G:T | K172N | 0.986 |
| 10:101594711:T:G | Y40D | 0.985 |
| 10:101594672:C:G | H27D | 0.984 |
dbSNP variants (sampled 300 via entrez): RS1000129686 (10:101593160 G>A), RS1000153970 (10:101607599 T>C), RS1000163331 (10:101593209 C>G,T), RS1000182354 (10:101606128 C>A), RS1000208148 (10:101607981 C>T), RS1000354698 (10:101586782 A>C), RS1000487268 (10:101605617 A>T), RS1000618098 (10:101606488 T>A), RS1000645496 (10:101598732 C>T), RS1000758849 (10:101591963 G>A), RS1000992457 (10:101606285 C>T), RS1001012227 (10:101587069 T>C), RS1001187033 (10:101587593 G>T), RS1001191258 (10:101592215 A>G), RS1001219678 (10:101604513 T>G)
Disease associations
OMIM: gene MIM:616467 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002392_547 | Mean corpuscular volume | 2.000000e-11 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 5 |
| Cyclosporine | decreases expression, increases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Ketoconazole | increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.